Authors


Lara V. Marcuse, MD

Latest:

Empowering Women to Develop Leadership Skills in Neurology: Lara V. Marcuse, MD

The codirector of the Mount Sinai Epilepsy Program at the Icahn School of Medicine at Mount Sinai talked about the Women in Neurology and Leadership session she spoke in at IFN 2023. [WATCH TIME: 3 minutes]


Daniel Bandari, MD, MS

Latest:

Key Points for the Management of Multiple Sclerosis

Stephen Krieger, MD; Daniel Bandari, MD, MS; Bruce Hughes, MD; Mitzi Williams, MD; and Heidi Crayton, MD, provide key takeaways for the treatment of patients with multiple sclerosis.


Justin Moy

Latest:

A Patient Perspective on Gene Therapy for Neuromuscular Diseases: Justin Moy

The second-year PhD student in bioinformatics at Boston University who lives with LAMA2 congenital muscular dystrophy talked about the potential impact and challenges of gene therapy in neuromuscular diseases. [WATCH TIME: 5 minutes]


Rajiv Jain, PhD

Latest:

Exploring New Therapies for MS With Research on T-bet+ memory B Cells: Rajiv Jain, PhD

At the 2023 ACTRIMS, the post-doctoral associate in the department of clinical neurosciences at the University of Calgary, spoke on the impact of researching T-Bet+ memory B cells for new therapies in multiple sclerosis. [WATCH TIME: 5 minutes]


Alise Carlson, MD

Latest:

Implications of Diagnosing and Misdiagnosing Multiple Sclerosis

Alise Carlson, MD, resident of Cleveland Clinic, details the factors and long-term effects misdiagnosing a patient with multiple sclerosis can have on their quality of life.


Andrew C. Charles, MD

Latest:

Future Directions for the Management of Migraine

Bradley Torphy, MD, and Julio R. Vieira, MD, share unmet needs and clinical pearls for the management of migraine.


Latisha Sharma, MD

Latest:

AUPN 2022 Spring Chairs Session: Simulations for Training in Neurology

David G. Standaert, MD, PhD; Wolfgang Muhlhofer, MD; and Latisha Sharma, MD, share their experience in applying simulation-based learning in Neurology and will discuss the current state and future potential of this approach. [WATCH TIME: 1 hour, 25 minutes]


Nikita Chhabra, DO

Latest:

Exploring the Risk of Hypertension Following Erenumab Treatment for Migraine: Nikita Chhabra, DO

The neurology PGY-3 at Mayo Clinic in Arizona talked about findings from a retrospective cohort study that examined blood pressure in patients who were prescribed a migraine medication. [WATCH TIME: 6 minutes]


Jiya Desai

Latest:

The Impact of a Social Media–Based Educational Intervention to Promote Training in Social Determinants of Health Among Medical Residents

Social determinants of health are conditions that people are born into and live under that affect their health, and can greatly impact clinical outcomes as well as contribute to health disparities and inequalities.


Claudene J. George, MD

Latest:

Digital Health Tool Offers Innovative Quantitative Fall Assessment Solution for Older Adults

Falls cost the US more than $50 billion annually, but platforms like CatchU, a transformative digital health tool, provide quantitative fall assessment that might significantly enhance the current standard of care for predicting falls.


Jeffrey Dunn, MD

Latest:

Tools and Resources for the Management of MS

Drs Jeffrey Dunn and Regina Berkovich review available tools and resources for the care of patients with multiple sclerosis, focusing on specific symptoms.


Larry Hanover

Latest:

Tapping Into the Potential of Cell and Gene Therapy

Advancements in gene therapy approaches have opened the door for a glimpse into the future of care for a number of diseases.


Brandon Giglio, MD

Latest:

Educating the Public on the Common Risk Factors for Stroke Awareness: Brandon Giglio, MD

The director of vascular neurology at NYU Langone Hospital in Brooklyn discussed the high prevalence of common risk factors for stroke, emphasizing the importance of early detection and management for prevention. [WATCH TIME: 4 minutes]


Tom Leist, MD

Latest:

New Horizons in Multiple Sclerosis

Experts share insights on the latest innovations in multiple sclerosis research, in highlights from a recent State of the Science SummitTM, presented by Neurology Live®.


Tracy Salazar, PhD

Latest:

Role of Advocacy Organizations in Seizure Action Plans, Seizure Education

A roundtable discussion featuring Scott Perry, MD, Orrin Devinsky, MD, and Tracy Salazar, PhD, details how advocacy organizations can help guide patients with epilepsy and their caregivers with a seizure action plan.


Ashgan Elshinawy, DO

Latest:

Resources for Sleep Disorders

Drs C. Michael Gibson, Ashgan A. Elshinawy, and Nathaniel F. Watson share resources for the treatment of sleep disorders.



Mitzi Williams, MD

Latest:

Key Points for the Management of Multiple Sclerosis

Stephen Krieger, MD; Daniel Bandari, MD, MS; Bruce Hughes, MD; Mitzi Williams, MD; and Heidi Crayton, MD, provide key takeaways for the treatment of patients with multiple sclerosis.


Jiwon Oh, MD, PhD

Latest:

A Medical Preview of 2024 for Multiple Sclerosis and Related Disorders: Jiwon Oh, MD, PhD

The staff neurologist and medical director of the Barlo Multiple Sclerosis Program at St Michaels Hospital shared thoughts on the promising advancements in the multiple sclerosis field for 2024. [WATCH TIME: 5 minutes]


Fred Lado, MD, PhD

Latest:

Reviewing Updated Epilepsy Guidelines to Prioritize Outpatient Focus and Patient-Centric Approach: Fred Lado, MD, PhD

The professor of neurology at the Zucker School of Medicine at Hofstra-Northwell talked about recently updated epilepsy care guidelines that shift the focus to outpatient care, incorporating broader aspects like care coordination, medication access, and patient-identified needs. [WATCH TIME: 5 minutes]


Yinan Zhang, MD

Latest:

The Intricate Relationship Between Biological Aging and Multiple Sclerosis: Yinan Zhang, MD

The assistant professor of neurology at The Ohio State University Wexner Medical Center talked about results from an ongoing study assessing biological aging in patients with multiple sclerosis using epigenetic clocks and p16INK4a. [WATCH TIME: 6 minutes]


John W. Day, MD, PhD

Latest:

Advancements and Challenges in Genetic Treatments for Neuromuscular Diseases: John W. Day, MD, PhD

Ahead of the 2024 MDA Conference, the medical advisor and care center director at Muscular Dystrophy Association talked about the track sessions he will be cochairing at the meeting. [WATCH TIME: 5 minutes]


Douglas Kerr, MD

Latest:

Role of Advocacy Organizations in Creating Safe Spaces for Rare Disorders

A panel of neurology experts detailed the importance that community leadership and creating a positive environment can do for patients with rare neurologic disorders [WATCH TIME: 5 minutes]


Amber Salter, MPH, PhD

Latest:

How COViMS Registry Is Clarifying MS COVID-19 Risks: Amber Salter, MPH, PhD

The assistant professor of biostatistics at Washington University in St. Louis discussed what role the COViMS registry can play for the MS community at this stage in the pandemic.


Aaron Ritter, MD

Latest:

Future of Treating Parkinson Disease Psychosis, Overcoming Challenges in Clinical Trials: Aaron Ritter, MD

The director of the Memory & Cognitive Disorders Clinic at Hoag Neuroscience Institute provided perspective on the difficulties with testing agents for Parkinson disease psychosis, and the future outlook of treating the symptom. [WATCH TIME: 4 minutes]


Smathorn Thakolwiboon, MD

Latest:

Unravel the Mysteries of Multiple Sclerosis Mimics

Despite the diagnosis of MS improving, misdiagnosis remains a challenge, pointing to the need for proper differential diagnosis and mimic identification.



Federica Picariello, PhD

Latest:

Digital Treatment Approach May Help Reduce Healthcare Burden for MS Fatigue: Federica Picariello, PhD

The postdoctoral researcher and health psychologist at King's College London spoke at ECTRIMS 2022 about the digital approach to treating fatigue in multiple sclerosis and the lack of available measurements. [WATCH TIME: 3 minutes]


Sarah C. Stoney, MSW, LSW

Latest:

Examining Depression and Suicidality in Pediatric Patients With MS: Sarah C. Stoney, MSW, LSW

The social worker in the Pediatric Multiple Sclerosis Clinic at Children's Hospital of Philadelphia talked about depression and suicidality rates in pediatric patients with multiple sclerosis. [WATCH TIME: 5 minutes]


William Gallentine, DO

Latest:

New Frontiers in the Prevention of Seizures, Gene Therapy in Epilepsy: William Gallentine, DO

The interim chief of pediatric neurology at Stanford Medicine Children’s Health discussed progress in preventing seizures among patients with epilepsy, the potential for gene-targeted therapies, and the importance of localizing where seizures are coming from. [WATCH TIME: 5 minutes]

© 2024 MJH Life Sciences

All rights reserved.